Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease

Respiratory Research

Volumn 2, Issue 2, 2001, Pages 71-79

  Greenfeder, Scott ^a   Umland, Shelby P ^a   Cuss, Francis M ^a   Chapman, Richard W ^a   Egan, Robert W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Allergy; Asthma; Eosinophil; Interleukin 5

Indexed keywords

CYTOKINE; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; INTERLEUKIN 5 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 7; JANUS KINASE; MEPOLIZUMAB; MONOCLONAL ANTIBODY; PREDNISOLONE; PROTEIN TYROSINE KINASE; RESLIZUMAB; SCH 55700; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; BASOPHIL; BONE MARROW; CELL MATURATION; CELL TYPE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG TARGETING; EOSINOPHIL; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; MOUSE; NONHUMAN; PHASE 1 CLINICAL TRIAL; REVIEW; TH2 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ASTHMA; EOSINOPHILIA; HUMANS; INTERLEUKIN-5; TH2 CELLS;

EID: 0035722930     PISSN: 14659921     EISSN: None     Source Type: Journal    
DOI: 10.1186/rr41     Document Type: Review

References (110)

1. Asthma and inflammation
2. Eosinophils
3. Recombinant human interleukin-5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays
4. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF
5. Regulation of human eosinophil precursor production by cytokines: A comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL-5, rhIL-6 and rh granulocyte-macrophage colony stimulating factor
6. Mutated interleukin-5 monomers are biologically inactive
7. Enhancement of human basophil histamine release by interleukin 5
8. Mechanisms of eosinophil recruitment
9. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5 specific α chain and a β chain shared with the receptor for GM-CSF
10. Cytokine receptors and signal transduction
11. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung
12. Mechanisms of allergic pulmonary eosinophilia in the mouse
13. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma
14. Effects of an antibody to IL-5 in a monkey model of asthma
15. Bronchoalveolar eosinophilia during antigen-induced late asthmatic reactions
16. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils and their progenitors
17. Early and late-phase bronchoconstriction after antigen challenge of nonanesthetized guinea pigs. 1. The association of disordered airway physiology to leukocyte infiltration
18. Inhibition of antigen-induced airway hyperresponsiveness but not acute hypoxia nor airway eosinophilia, by an antagonist of platelet-activating factor
19. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
20. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses
21. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response
22. Results of a phase I trial with SCH55700, a humanized anti-IL-5 antibody, in severe persistent asthma
23. Molecular organization of the cytokine gene cluster, involving, the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5
24. Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue
25. Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II
26. Characterization of the mouse granulocyte macrophage colony-stimulating factor (GM-CSF) gene promoter: Nuclear factors that interact with an element shared by three lymphokine genes - Those for GM-CSF, interleukin-4 (IL-4), and IL-5
27. Structure of recombinant human interleukin 5 produced by chinese hamster ovary cell
28. Structural comparison of murine T-cell (BI 51 KI 2) derived T-cell-replacing factor (IL-5) with rIL-5: Dimer formation is essential for the expression of biological activity
29. Delineation of IL-5 domains predicted to engage the IL-5 receptor complex
30. Mapping and characterization of the epitope(s) of Sch 55700, a humanized mAb, that inhibits human IL-5
31. Role of the C-terminus in the biological activity of human interleukin 5
32. Role of carbohydrate moiety of IL-5
33. A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5
34. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
35. Molecular events mediating T cell activation
36. TCR-dependent and independent signaling mechanisms differentially regulate lymphokine gene expression in the murine T helper clone DIO.G4.1
37. The regulation of interleukin-5 and interleukin-3 gene expression in human T cells
38. T cells are necessary for TH2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice
39. Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-γ
40. Effects of cyclosporin A and dinactin on T-cell proliferation, interleukin-5 production, and murine pulmonary inflammation
41. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines
42. Interleukin 5 synthesis by eosinophils: Association with granules and immunoglobulin-dependent secretion
43. Structural design and molecular evaluation of a cytokine receptor superfamily
44. Characterization of the human IL-5 receptors on eosinophils
45. Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells
46. Molecular cloning and expression of the human interleukin 5 receptor
47. Signaling by the cytokine receptor superfamily: JAKs and STATs
48. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
49. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologues
50. Regulation of human eosinophil production and function by interleukin-5
51. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors
52. Modulation of eosinophil chemotaxis by interleukin-5
53. The infuence of IL-3, IL-5 and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation
54. Release of granule proteins from eosinophils cultured with IL-5
55. Analysis of the survival of mature human eosinophils: Interleukin-5 prevents apoptosis in mature human eosinophils
56. Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters
57. Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen lung challenge
58. Glucocorticoids inhibit cytokine-mediated eosinophil survival
59. IgA-induced eosinophil degranulation
60. Activation of phospholipase D in normodense human eosinophils
61. Respiratory burst of normal human eosinophils
62. Eosinophils do respond to FMLP
63. Exclusive leukotrine C4 synthesis by purified human eosinophils induced by opsonized zymosan
64. G-protein-regulated phospholipase C, D, and A2-mediated signalling in neutrophils
65. Neutrophils and host defense
66. The eosinophilic leukocyte: Structure and function
67. The molecular biology of eosinophil granule proteins
68. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch
69. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium
70. Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea pigs
71. Effects of interleukin 5-induced pulmonary eosinophilia on airway reactivity in the guinea pig
72. Autocrine interaction between IL-5 and IL-1β mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle
73. Pretreatment with an antibody to interleukin 5 prevents loss of pulmonary M2 muscarinic receptor function in antigen challenged guinea pigs
74. Characterization of a murine model of allergic pulmonary inflammation
75. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: Prophylactic and therapeutic effect of an anti-IL-5 antibody
76. Mast cells modulate allergic pulmonary eosinophilia in mice
77. Attenuation of allergic airway inflammation in IL-4 deficient mice
78. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity
79. The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity
80. Antigen-induced acute and late-phase responses in primates
81. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage
82. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics
83. Detection of interleukin-5 messenger RNA and interleukin-5 protein in bronchial biopsies from asthma by nonradioactive in situ hybridization and immunohistochemistry
84. Interleukin-5 mRNA in mucosal bronchial biopsies from asthmatic subjects
85. Analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma
86. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in asthma
87. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
88. Increases in activated T lymphocytes, eosinophils and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics
89. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia
90. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon γ cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and subjects
91. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis
92. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects
93. Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin
94. Immuno-localization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects
95. T cells are the principal source of interleukin 5 mRNA in allergen-induced rhinitis
96. Eosinophils, bronchial hyperreactivity and late phase asthmatic reactions
97. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: Relationship to bronchial hyperreactivity
98. IL-5 is the predominant eosinophil-active cytokine in the antigen induced pulmonary late-phase reaction
99. + T cells, increased Th2-type cytokine mRNA expression and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
100. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators
101. Interleukin-5 preferentially recruits eosinophils from vessels in nasal mucosa
102. The effect of recombinant human interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa
103. CD4 T-Lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5
104. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma
105. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage
106. sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response
107. Inhibition of interleukin-5 gene expression by dexamethasone
108. Effect of SCH 55700, a humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivity
109. Inhibition of eosinophilia in monkeys with SB-240563, a humanized anti-human IL-5 monoclonal antibody
110. Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys